Endocrine Disruptors Fludioxonil and Fenhexamid Stimulate miR-21 Expression in Breast Cancer Cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endocrine Disruptors Fludioxonil and Fenhexamid Stimulate miR-21 Expression in Breast Cancer Cells
Authors
Keywords
-
Journal
TOXICOLOGICAL SCIENCES
Volume 131, Issue 1, Pages 71-83
Publisher
Oxford University Press (OUP)
Online
2012-10-12
DOI
10.1093/toxsci/kfs290
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
- (2012) Marilena V. Iorio et al. EMBO Molecular Medicine
- Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
- (2012) Laura N. Vandenberg et al. ENDOCRINE REVIEWS
- Role of microRNAs in the regulation of drug metabolizing and transporting genes and the response to environmental toxicants
- (2012) Igor Koturbash et al. Expert Opinion on Drug Metabolism & Toxicology
- Residues behavior of some fungicides applied on two greenhouse tomato varieties different in shape and weight
- (2012) Maddalena Cabizza et al. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART B-PESTICIDES FOOD CONTAMINANTS AND AGRICULTURAL WASTES
- A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts
- (2012) Judit Ribas et al. NUCLEIC ACIDS RESEARCH
- Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma Cells
- (2012) Syreeta L. Tilghman et al. PLoS One
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
- (2012) Hongjiang Wang et al. PLoS One
- miRNAs and estrogen action
- (2012) Carolyn M. Klinge TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Endocrine Disruptors: From Endocrine to Metabolic Disruption
- (2011) Cristina Casals-Casas et al. Annual Review of Physiology
- Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients
- (2011) K B Lundin et al. BRITISH JOURNAL OF CANCER
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells
- (2011) Tissa T. Manavalan et al. CANCER LETTERS
- Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
- (2011) Jessica L L Robinson et al. EMBO JOURNAL
- Minireview: Recent Advances in Extranuclear Steroid Receptor Actions
- (2011) Stephen R. Hammes et al. ENDOCRINOLOGY
- Widely Used Pesticides with Previously Unknown Endocrine Activity Revealed as in Vitro Antiandrogens
- (2011) Frances Orton et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis
- (2011) Xiaonan Fu et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Determination of famoxadone, fenamidone, fenhexamid and iprodione residues in greenhouse tomatoes
- (2011) Alberto Angioni et al. PEST MANAGEMENT SCIENCE
- Androgens and breast cancer
- (2011) Joanne Kotsopoulos et al. STEROIDS
- Aryl Hydrocarbon Receptor Modulation of Estrogen Receptor α-Mediated Gene Regulation by a Multimeric Chromatin Complex Involving the Two Receptors and the Coregulator RIP140
- (2011) Zeynep Madak-Erdogan et al. TOXICOLOGICAL SCIENCES
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
- (2010) Mark E. Hatley et al. CANCER CELL
- Intracellular and Extracellular MicroRNAs in Breast Cancer
- (2010) C. Corcoran et al. CLINICAL CHEMISTRY
- Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells
- (2010) Mineko Terao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-21 Is a Downstream Effector of AKT That Mediates Its Antiapoptotic Effects via Suppression of Fas Ligand
- (2010) Danish Sayed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription
- (2010) Carolyn M. Klinge et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Analysis of the mutations induced by conazole fungicides in vivo
- (2010) J. A. Ross et al. MUTAGENESIS
- Androgen regulation of micro-RNAs in prostate cancer
- (2010) Kati K. Waltering et al. PROSTATE
- MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells
- (2009) Tao Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Widespread Estrogen-Dependent Repression of microRNAs Involved in Breast Tumor Cell Growth
- (2009) G. Maillot et al. CANCER RESEARCH
- Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
- (2009) Evanthia Diamanti-Kandarakis et al. ENDOCRINE REVIEWS
- Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders
- (2009) Elin Swedenborg et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells
- (2009) Nalinie S. Wickramasinghe et al. NUCLEIC ACIDS RESEARCH
- Plasma membrane estrogen receptors
- (2009) Ellis R. Levin TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Genetic Analysis of Fenhexamid-Resistant Field Isolates of the Phytopathogenic Fungus Botrytis cinerea
- (2008) S. Fillinger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Environmental Chemicals and Breast Cancer Risk – A Structural Chemistry Perspective
- (2008) Jamie Weyandt et al. CURRENT MEDICINAL CHEMISTRY
- miR-21 Gene Expression Triggered by AP-1 Is Sustained through a Double-Negative Feedback Mechanism
- (2008) Shuji Fujita et al. JOURNAL OF MOLECULAR BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now